BY3-14981-88403
4 vaccinations
19 coded responses
50 check-ins
19 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 201 / VA
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Pfizer-BioNTech
-
2021-03-18
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · Site: PainFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-20
-
2021-03-21
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · Site: PainFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — day 7, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
-
2021-04-08
Dose 2 — Pfizer-BioNTech
-
2021-04-08
Survey response — day 0, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Good · Site: Pain · HeadacheFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Survey response — day 7, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-23
- 2021-04-29
-
2021-05-06
Survey response — day 28, dose 2MedDRA: Heavy menstrual bleeding, Polymenorrhoea — Feeling: GoodFree text: My last two menstrual cycles have been unusually short (e.g., 23 days) and included unusually heavy bleeding. I do not know whether to attribute this to the vaccine, to menopause, or to both.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-13
- 2021-05-20
- 2021-07-08
- 2021-10-07
-
2021-10-28
Dose 3 — Pfizer-BioNTech
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-26
- 2021-12-04
- 2021-12-11
-
2022-04-28
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: 10-day cold symptoms, assumed virus. At-home test was negative for COVID-19.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-11
Dose 4 — Moderna
-
2022-10-11
Survey response — day 0, dose 4MedDRA: Fatigue, Hypersomnia — Feeling: GoodFree text: Flu vaccine on 10/6/2022 resulted in extreme fatigue on 10/8/2022 (sleeping extra 5-7 hours on top of regular 8)MedDRA releases: 2024-11 · check-in free text available
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-20
- 2022-10-25
-
2022-11-03
Survey response — day 21, dose 4MedDRA: Fatigue, Nasopharyngitis, Oropharyngeal pain, Paranasal sinus discomfort, Respiratory tract congestion, SARS-CoV-2 test negative, Sinus congestion, Sneezing — Feeling: Poor · Be unable to do your normal daily activitiesFree text: I have a cold. Day 1: sore throat. Days 2 and 3: increasing congestion. Day 4: sneezing, sinus pressure/congestion, fatigue. Days 5-10: TBD. At-home COVID tests negative.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-08
Survey response — day 28, dose 4MedDRA: Dysphonia, Nasal congestion, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: FairFree text: I am on day 9 of a cold. Symptoms are mild and have progressed as one would expect for the common cold. At this point, I am experiencing nasal congestion and vocal hoarseness. My at-home COVID test was negative.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-15
- 2022-11-22
- 2023-01-10
- 2023-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech | |
| 3 | 2021-10-28 | Pfizer-BioNTech | No |
| 4 | 2022-10-11 | Moderna | No |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): No
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): No
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Release 6 — day 7, dose 1
Systemic reaction (other): No
Release 7 — day 0, dose 2
Systemic reaction (other): No
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Release 7 — day 7, dose 2
Systemic reaction (other): No
Release 8 — day 28, dose 2
Symptoms: My last two menstrual cycles have been unusually short (e.g., 23 days) and included unusually heavy bleeding. I do not know whether to attribute this to the vaccine, to menopause, or to both.
Release 11 — 6 months, dose 3
Symptoms: 10-day cold symptoms, assumed virus. At-home test was negative for COVID-19.
Release 12 — day 0, dose 4
Systemic reaction (other): Flu vaccine on 10/6/2022 resulted in extreme fatigue on 10/8/2022 (sleeping extra 5-7 hours on top of regular 8)
Release 12 — day 21, dose 4
Symptoms: I have a cold. Day 1: sore throat. Days 2 and 3: increasing congestion. Day 4: sneezing, sinus pressure/congestion, fatigue. Days 5-10: TBD. At-home COVID tests negative.
Release 12 — day 28, dose 4
Symptoms: I am on day 9 of a cold. Symptoms are mild and have progressed as one would expect for the common cold. At this point, I am experiencing nasal congestion and vocal hoarseness. My at-home COVID test was negative.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dysphonia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Polymenorrhoea | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Hypersomnia | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release